
Sign up to save your podcasts
Or
Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com
4.9
8585 ratings
Today we’re talking to Peter Rahfeld, CSO of ABOzymes; and we discuss how Peter’s company hopes to make blood types obsolete by being able to change any blood to Type O. Learn about the science and the business behind this breakthrough right here, right now, on the Modern CTO Podcast!
Learn more at https://www.abozymes.com
1,273 Listeners
152 Listeners
1,033 Listeners
519 Listeners
175 Listeners
331 Listeners
3,995 Listeners
217 Listeners
267 Listeners
192 Listeners
443 Listeners
121 Listeners
75 Listeners
479 Listeners
63 Listeners